ABSTRACT The endogenous Moloney leukemia virus (MMuLV) in the BALB/Mo substrain of mice is activated during the first week after birth. Virus replication occurs in cells of the lymphatic system. Lymphoid cells therefore represent the target cells for virus replication and leukemic transformation. To investigate whether virus activation occurs during lymphoid cell differentiation, hematopoietic stem cells carrying the endogenous Mov-1 genome were transplanted to sublethally irradiated BALB/c mice. Effective colonization of the recipients was demonstrated by Southern DNA hybridization. No activation of the endogenous Mov-1 genome occurred during a 4-month observation period after the transplantation. Thus the first step in development of disease in BALB/Mo mice involves activation of the Mov-1 locus in a nonhematopoietic cell followed by superinfection oflymphatic cells and subsequent virus replication and virus spread.
Murine leukemia viruses (MuLVs) such as the AKR and Moloney strains integrate the proviral genome into lymphoid cells and transform specifically T cells by an unknown mechanism (1, 2) . BALB/Mo mice transmit the exogenous Moloney MuLV (M-MuLV) as a Mendelian gene (3) . The viral genome was shown to be integrated on-chromosome 6, and this genetic locus was named Mov-1 (4). Virus is activated soon after birth, and activation is followed by somatic proviral DNA amplification and virus expression in the lymphatic tissues-spleen and thymus (5, 6) . Thus, cells of the lymphatic tissues represent the target cells for virus infection and for virus replication and therefore carry two types of M-MuLV copies: the endogenous, genetically transmitted copy at the Mov-1 locus and somatically acquired "exogenous" copies. Thymus-specific leukemia develops several months later. All three events-i.e., virus expression, provirus DNA amplification, and development of leukemia-can be prevented by injecting newborn BALB/Mo mice with anti-M-MuLV antiserum (7) . Thus, superinfection of lymphoid cells appears to be an essential step for the development of viremia. The available evidence suggests that activation of the endogenous M-MuLV in BALB/Mo mice as well as in other substrains developed in this laboratory occurs at specific stages of development and differentiation (8, 9) . To better understand the relationship between differentiation and virus genome activation, we investigated whether activation of the Mov-l genome occurs in the same cell type that is the target cell for replication and transformation. For Radioimmunoassay. The concentration of the M-MuLV internal protein p30 was determined by competitive radioimmunoassay with radioiodinated M-MuLV p30 and rabbit antiserum directed at p30 (7, 11) .
Cell Transfer. Single cell suspensions were prepared by mincing organs in Dulbecco's modified Eagle's medium. The cells were filtered through a Nyltex 100-,um-pore filter to remove the stromal tissues. Bone marrow was obtained by flushing the femurwith the modified Eagle's medium. The cells were washed twice by centrifugation and resuspended in the modified Eagle's medium. Viable cells were counted by use oftrypan blue solution, and 107, 106, or 105 cells were injected into the tail vein of irradiated mice.
Irradiation of Mice. BALB/c males were irradiated with 800 to 900 rads (1 rad = 0.01 gray), using an x-ray source (12) .
DNA Extraction and Restriction Enzyme Analysis. Spleen, thymus, and liver were obtained from recipient BALB/c mice 4 months after transfer and high molecular weight DNA was extracted as described (6) .
The DNA was digested with EcoRI restriction endonuclease, separated on 0.5% agarose gels, blot transferred to nitrocellulose filters, and hybridized to 32P-labeled M-MuLV cDNA as described (6) .
Antiserum Treatment. Antiserum-treated mice heterozygous at the Mov-1 locus were obtained as described (7) . BALB/ c females mated with BALB/Mo homozygous males were injected with 0.3 ml of rabbit anti-M-MuLV serum at day 15 of gestation. The newborn mice were injected with antiserum at the day of birth and subsequently at weekly intervals (7) .
RESULTS
Virus Is Not Activated in Transplanted BALB/Mo F1 Cells. We have shown previously that viremic mothers transmit virus efficiently to their offspring by congenital infection (13) . Therefore, to obtain donor animals that have not been exposed to maternal exogenous virus, cells were isolated from embryos or adults heterozygous at the Mov-1 locus [(BALB/c X BALB/ Mo)F1]. These animals were derived by mating BALB/c females with homozygous BALB/Mo males and for simplicity will be referred to as BALB/Mo F1 mice.
Abbreviations: MuLV, murine leukemia virus; M-MuLV, Moloney strain of MuLV; kb, kilobase(s).
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The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. Fetal liver or thymus cells from BALB/Mo F1 embryos or cells from spleen, bone marrow, or thymus from adults that had been treated with anti-M-MuLV antiserum were transferred to irradiated BALB/c mice. It has been shown that no infectious virus is present in BALB/Mo F1 embryos (9) or in anti-MMuLV-treated BALB/Mo F1 adults (7). Thus no "exogenous" M-MuLV copies were present in the transferred cells, and development of virus in the recipient animals would be due to activation of the endogenous M-MuLV genome. Table 1 shows that 20% of BALB/c mice survived irradiation with 800-900 rad. Survival was increased to approximately 80% when the irradiated mice were reconstituted with liver, thymus, spleen, or bone marrow cells from BALB/Mo F1 embryos or from adult mice. The results suggest that transplanted BALB/ Mo F1 cells colonized the irradiated recipients efficiently.
Virus activation was monitored by testing the recipients for viremia. The animals were bled every other week for a period of4 months and the serum was tested for M-MuLV p30 by using a radioimmunoassay. Table 2 shows that none of the recipients developed viremia after being grafted with as many as 10' cells from BALB/Mo F1 embryos or anti-M-MuLV-treated adults.
The following controls were performed to estimate the number of infectious units required to induce viremia in adult recipients. Unirradiated 8-week-old BALB/c mice were grafted with serial dilutions ofspleen or thymus cells that were obtained from untreated, viremic adult BALB/Mo F1 mice. Table 3A shows that viremia developed within 2-3 weeks even in recipients of as few as 100 cells. We have estimated previously that 10 Extracts from spleens were prepared 4 months after reconstitution or from control mice and the concentration of p30 was determined by competitive radioimmunoassay (7, 11) . * Cells from different embryos were tested independently.
( Fig. 1 A and B, lanes a and b) and a 1:1 mixture of both heterozygous BALB/Mo DNA and BALB/c DNA ( Fig. 1 A By comparing the intensity of the 27-kb band in DNA from the experimental animals with that in DNA of the reconstruction experiments, it is estimated that the cell population in spleen and thymus of the animal in Fig. 1A contained 50-70% BALB/Mo F1 cells; in the same organs from the animals in Fig.  1B and C, 20-50% were of BALB/Mo F1 origin. Analyses of the kind shown in Fig. 1 confirmed that BALB/Mo F1 cells had repopulated the reconstituted BALB/c recipients and that 4 months after grafting between 20% and 70% of the lymphatic cell population were of donor origin.
DISCUSSION
The endogenous M-MuLV is activated invariably in every BALB/Mo mouse during the first week after birth (3, 9) , leading to a predominantly lymphotropic expression of M-MuLV (5). The age-dependent kinetics of expression of viral RNA and of appearance of infectious virus in different tissues of BALB/Mo mice has been quantitatively determined previously (5, 7, 9) . Other substrains of mice developed in this laboratory activate virus at different stages during their development, leading to distinct phenotypes of tissue-specific virus expression. In the Mov-13 substrain, for example, virus is activated during embryogenesis, leading to virus expression in lymphatic as well as nonlymphatic tissue (9) .
Proc. Nad Acad. Sci (ii) Activation ofvirus can occur in any cell with a given probability. This probability would be higher in Mov-13 than in BALB/Mo mice. The tissue-specific pattern ofvirus expression in the adult then would be due to superinfection of target cell populations that are different at different stages of development (13) .
Previous experiments have shown that viral RNA in BALB/ Mo mice is detected first in spleens and thymuses of newborn animals. This led to the hypothesis that lymphatic cells may be the ones in which the endogenous Mov-1 locus is activated (5, 8) . However, because lymphatic cells acquire new exogenous M-MuLV copies by superinfection, it was not possible to decide whether virus replication reflected the primary transcription of the endogenous Mov-1 gene in the lymphatic cell or, rather, was due to superinfection with virus activated in some other cells.
The present experiments were undertaken to distinguish between these possibilities. Hematopoietic and lymphopoietic cells carrying the endogenous M-MuLV genome at the Mov-1 locus only were transplanted to BALB/c mice. The recipients were irradiated with a sublethal dose to enhance survival and colonization by the donor cells. The overall survival rate of the irradiated mice increased from 20% to 80% after reconstitution, suggesting that donor cells had colonized the recipients. This conclusion was supported by the restriction enzyme analysis of DNA from spleen and thymus (Fig. 1) , showing that 20-70% of the cells in lymphatic tissues of the transplanted BALB/c mice were of BALB/Mo F1 origin. Although we have not characterized the type of BALB/Mo F1 cells present, it appears likely that pluripotent stem cells from fetal liver, bone marrow, and spleen give rise to clones that differentiated along lymphopoietic as well as erythropoietic pathways (14) (15) (16) . Transplanted thymic cells, however, should contain committed stem cells with a restricted potential for differentiation only. This is compatible with the observation that the fraction of BALB/Mo F1 cells in animals reconstituted with 107 thymus cells was lower than in animals reconstituted with 107 fetal liver cells (Fig. 1) .
None of the recipients developed viremia or had p30 in their lymphatic tissues during a period of 4 months after transplantation. Viremia is a highly sensitive indicator for virus expression because injection of as few as 10 infectious units into unirradiated adults will lead to a general infection of the hematopoietic system followed by high virus titers in the serum (Table 3) . Our results therefore indicate that the Mov-l locus was not activated in donor cells, which presumably had undergone all steps of lymphopoietic and erythropoietic cell differentiation (15) during a 4-month period after their transfer.
The hematopoietic system has a high cell turnover rate. It has been estimated, for example, that the total population of 2 x 108 cells in the thymus of a 6-week-old mouse is renewed every 4-5 days (17) . Assuming that 500-5000 pluripotent stem cells are present in 107 fetal liver or adult bone marrow cells (16, 18) , it could be estimated that 35-40 cell divisions were required to repopulate just the thymus of the irradiated host and to permit cell renewal for a period of 4 months after transplantation. (19) . That cell division per se does not activate the Mov-1 locus is also supported by the failure of BALB/Mo fibroblasts to produce virus even after prolonged growth in tissue culture (4, 20) . Therefore infectious virus appearing in every BALB/Mo animal during the first week after birth (5, 9) probably originates in cells of nonhematopoietic origin: Our results indicate that virus is activated at a specific stage of differentiation in a specific cell population, as has been proposed earlier (8) . The mechanism of tissue-specific genome activation, however, remains to be defined.
